compounding glp-1 Managing Compounded Medications: A Pharmacist's Guide for Employers – Sequoia Novo Nordisk asks FDA not
Description
Early initiation of metformin treatment plus an SGLT-2 inhibitor is recommended in most people with type 2 diabetes, followed by the addition of glucose-lowering agents as needed to achieve individualised glycaemic targets (Table 2)
Additionally, a study published in The Lancet in February 2026 found that taking Foundayo, Eli Lillys GLP-1 pill that was approved by the FDA in April, resulted in greater weight loss and blood sugar level reductions compared to Rybelsus, another oral GLP-1 manufactured by Novo Nordisk
Were also defining the market too narrowly
Remove the patch from its liner
